• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用卟啉单胞菌素-PDT 的单线态氧裂解前药对大鼠非肌肉浸润性膀胱癌进行红光和绿光治疗的比较。

Comparison of red and green light for treating non-muscle invasive bladder cancer in rats using singlet oxygen-cleavable prodrugs with PPIX-PDT.

机构信息

Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA.

Department of Pharmacology & Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

出版信息

Photochem Photobiol. 2024 Nov-Dec;100(6):1659-1675. doi: 10.1111/php.13933. Epub 2024 Mar 27.

DOI:10.1111/php.13933
Abstract

It has been 30 years since Photofrin-PDT was approved for the treatment of bladder cancer in Canada. However, Photofrin-PDT failed to gain popularity due to bladder complications. The PDT with red light and IV-administered Photofrin could permanently damage the bladder muscle. We have been developing a new combination strategy of PpIX-PDT with singlet oxygen-cleavable prodrugs for NMIBC with minimal side effects, avoiding damage to the bladder muscle layer. PpIX can be excited by either green (532 nm) or red (635 nm) light. Red light could be more efficacious in vivo due to its deeper tissue penetration than green light. Since HAL preferentially produces PpIX in tumors, we hypothesized that illuminating PpIX with red light might spare the muscle layer. PpIX-PDT was used to compare green and red laser efficacy in vitro and in vivo. The IC of in vitro PpIX-PDT was 18 mW/cm with the red laser and 22 mW/cm with the green laser. The in vivo efficacy of the red laser with 50, 75, and 100 mW total dose was similar to the same dose of green laser in reducing tumor volume. Combining PpIX-PDT with prodrugs methyl-linked mitomycin C (Mt-L-MMC) and rhodamine-linked SN-38 (Rh-L-SN-38) significantly improved efficacy (tumor volume comparison). PpIX-PDT or PpIX-PDT + prodrug combination did not cause muscle damage in histological analysis. Overall, a combination of PpIX-PDT and prodrug with 635 nm laser is promising for non-muscle invasive bladder cancer treatment.

摘要

自 Photofrin-PDT 在加拿大被批准用于膀胱癌治疗以来,已经过去了 30 年。然而,由于膀胱并发症,Photofrin-PDT 并未普及。使用红光和静脉注射 Photofrin 的 PDT 会永久性地损伤膀胱肌肉。我们一直在开发一种新的组合策略,即使用卟啉啉-PDT 与单重态氧可裂解前药联合治疗非肌肉浸润性膀胱癌,以最小的副作用避免膀胱肌肉层损伤。PpIX 可以被绿光(532nm)或红光(635nm)激发。由于红光的组织穿透深度比绿光更深,因此在体内可能更有效。由于 HAL 优先在肿瘤中产生 PpIX,我们假设用红光照射 PpIX 可能会使肌肉层免受损伤。我们使用 PpIX-PDT 比较了体外和体内的绿光和红光激光疗效。体外 PpIX-PDT 的 IC 为 18mW/cm 时用红光,22mW/cm 时用绿光。50、75 和 100mW 总剂量的红光激光的体内疗效与相同剂量的绿光激光在减少肿瘤体积方面相似。将 PpIX-PDT 与前药甲基连接丝裂霉素 C(Mt-L-MMC)和罗丹明连接 SN-38(Rh-L-SN-38)联合使用可显著提高疗效(肿瘤体积比较)。在组织学分析中,PpIX-PDT 或 PpIX-PDT+前药联合治疗均未引起肌肉损伤。总的来说,635nm 激光联合 PpIX-PDT 和前药治疗非肌肉浸润性膀胱癌具有广阔的前景。

相似文献

1
Comparison of red and green light for treating non-muscle invasive bladder cancer in rats using singlet oxygen-cleavable prodrugs with PPIX-PDT.采用卟啉单胞菌素-PDT 的单线态氧裂解前药对大鼠非肌肉浸润性膀胱癌进行红光和绿光治疗的比较。
Photochem Photobiol. 2024 Nov-Dec;100(6):1659-1675. doi: 10.1111/php.13933. Epub 2024 Mar 27.
2
Preclinical evaluation of singlet oxygen-cleavable prodrugs in combination with protoporphyrin IX-photodynamic therapy in an orthotopic rat model of non-muscle-invasive bladder cancer.在非肌肉浸润性膀胱癌的原位大鼠模型中,评估单线态氧可裂解前药与原卟啉 IX-光动力疗法联合应用的临床前评价。
Photochem Photobiol. 2024 Nov-Dec;100(6):1590-1602. doi: 10.1111/php.13838. Epub 2023 Jul 20.
3
Mitochondrial targeting improves the selectivity of singlet-oxygen cleavable prodrugs in NMIBC treatment.线粒体靶向提高了用于 NMIBC 治疗的单重态氧可裂解前药的选择性。
Photochem Photobiol. 2024 Nov-Dec;100(6):1622-1635. doi: 10.1111/php.13928. Epub 2024 Mar 3.
4
Enhancing PDT efficacy in NMIBC: Efflux inhibitor mediated improvement of PpIX levels and efficacy of the combination of PpIX-PDT and SO-cleavable prodrugs.提高非肌层浸润性膀胱癌 PDT 疗效:外排泵抑制剂介导的原卟啉 IX 水平提高和原卟啉 IX-PDT 与 SO 可切割前药联合应用的疗效改善。
Photochem Photobiol. 2024 Nov-Dec;100(6):1636-1646. doi: 10.1111/php.13982. Epub 2024 Jun 12.
5
Photodynamic Therapy for Bladder Cancers, A Focused Review.光动力疗法治疗膀胱癌,重点综述。
Photochem Photobiol. 2023 Mar;99(2):420-436. doi: 10.1111/php.13726. Epub 2022 Oct 14.
6
Singlet Oxygen Activatable Prodrugs of Paclitaxel, SN-38, MMC and CA4: Nonmitochondria-Targeted Prodrugs.紫杉醇、SN-38、MMC 和 CA4 的单线态氧激活前药:非线粒体靶向前药。
Photochem Photobiol. 2022 Mar;98(2):389-399. doi: 10.1111/php.13589. Epub 2022 Jan 11.
7
Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.组合式铁螯合原卟啉 IX 前药用于荧光检测和光动力治疗的实验研究。
Lasers Med Sci. 2022 Mar;37(2):1155-1166. doi: 10.1007/s10103-021-03367-1. Epub 2021 Jul 4.
8
Analysis of differential PDT effect in rat bladder tumor models according to concentrations of intravesical hexyl-aminolevulinate.根据膀胱内六氨基乙酰丙酸浓度分析大鼠膀胱肿瘤模型中的光动力疗法差异效应
Photochem Photobiol Sci. 2008 Sep;7(9):1018-24. doi: 10.1039/b804921a. Epub 2008 Jul 23.
9
A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.皮肤 ALA-PDT 的动力学模型:基态氧、光敏剂和单线态氧的时空分布模拟。
Phys Med Biol. 2010 Oct 7;55(19):5913-32. doi: 10.1088/0031-9155/55/19/019. Epub 2010 Sep 16.
10
Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.通过开发新型铁螯合氨基酮戊酸前药来提高体外光动力疗法。
Photodiagnosis Photodyn Ther. 2019 Mar;25:157-165. doi: 10.1016/j.pdpdt.2018.12.005. Epub 2018 Dec 13.

引用本文的文献

1
Metronomic photodynamic therapy for deep organ cancer by implantable wireless OLEDs.用于深部器官癌症的可植入式无线有机发光二极管节律性光动力疗法。
APL Bioeng. 2025 Apr 30;9(2):026113. doi: 10.1063/5.0256898. eCollection 2025 Jun.
2
A Comprehensive Review of Current Approaches in Bladder Cancer Treatment.膀胱癌治疗当前方法的综合综述
ACS Pharmacol Transl Sci. 2025 Jan 6;8(2):286-307. doi: 10.1021/acsptsci.4c00663. eCollection 2025 Feb 14.

本文引用的文献

1
Preclinical evaluation of singlet oxygen-cleavable prodrugs in combination with protoporphyrin IX-photodynamic therapy in an orthotopic rat model of non-muscle-invasive bladder cancer.在非肌肉浸润性膀胱癌的原位大鼠模型中,评估单线态氧可裂解前药与原卟啉 IX-光动力疗法联合应用的临床前评价。
Photochem Photobiol. 2024 Nov-Dec;100(6):1590-1602. doi: 10.1111/php.13838. Epub 2023 Jul 20.
2
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
A Phase 1b Clinical Study of Intravesical Photodynamic Therapy in Patients with Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer.
卡介苗无反应性非肌层浸润性膀胱癌患者膀胱内光动力疗法的1b期临床研究
Eur Urol Open Sci. 2022 Jun 1;41:105-111. doi: 10.1016/j.euros.2022.04.015. eCollection 2022 Jul.
4
Singlet Oxygen Activatable Prodrugs of Paclitaxel, SN-38, MMC and CA4: Nonmitochondria-Targeted Prodrugs.紫杉醇、SN-38、MMC 和 CA4 的单线态氧激活前药:非线粒体靶向前药。
Photochem Photobiol. 2022 Mar;98(2):389-399. doi: 10.1111/php.13589. Epub 2022 Jan 11.
5
Photophysical Properties of Protoporphyrin IX, Pyropheophorbide-a and Photofrin in Different Conditions.原卟啉IX、焦脱镁叶绿酸-a及光卟啉在不同条件下的光物理性质
Pharmaceuticals (Basel). 2021 Feb 9;14(2):138. doi: 10.3390/ph14020138.
6
Clinical evaluation of smartphone-based fluorescence imaging for guidance and monitoring of ALA-PDT treatment of early oral cancer.基于智能手机的荧光成像在指导和监测早期口腔癌 ALA-PDT 治疗中的临床评价。
J Biomed Opt. 2020 Apr;25(6):1-10. doi: 10.1117/1.JBO.25.6.063813.
7
Light Sources and Dosimetry Techniques for Photodynamic Therapy.用于光动力疗法的光源和剂量测定技术。
Photochem Photobiol. 2020 Mar;96(2):280-294. doi: 10.1111/php.13219. Epub 2020 Mar 17.
8
Singlet oxygen-activatable Paclitaxel prodrugs via intermolecular activation for combined PDT and chemotherapy.通过分子间活化实现单线态氧可激活的紫杉醇前药用于光动力疗法和化疗联合治疗
Bioorg Med Chem Lett. 2019 Jun 15;29(12):1537-1540. doi: 10.1016/j.bmcl.2019.03.053. Epub 2019 Apr 2.
9
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
10
5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.5-氨基酮戊酸介导的膀胱癌光动力疗法
Int J Urol. 2017 Feb;24(2):97-101. doi: 10.1111/iju.13291.